Hepion Pharmaceuticals Stock Forecast - Accumulation Distribution
| HEPA Stock | USD 0.66 0.03 4.35% |
Hepion Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Hepion Pharmaceuticals stock prices and determine the direction of Hepion Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Hepion Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Hepion |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 759.44 | 1623.87 |
| Check Hepion Pharmaceuticals Volatility | Backtest Hepion Pharmaceuticals | Trend Details |
Hepion Pharmaceuticals Trading Date Momentum
| On November 24 2024 Hepion Pharmaceuticals was traded for 0.66 at the closing time. The top price for the day was 0.71 and the lowest listed price was 0.66 . There was no trading activity during the period 0.0. Lack of trading volume on November 24, 2024 did not cause price change. The trading delta at closing time against the current closing price is 7.58% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Hepion Pharmaceuticals to competition |
Other Forecasting Options for Hepion Pharmaceuticals
For every potential investor in Hepion, whether a beginner or expert, Hepion Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Hepion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Hepion. Basic forecasting techniques help filter out the noise by identifying Hepion Pharmaceuticals' price trends.Hepion Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hepion Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Hepion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hepion Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Hepion Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Hepion Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Hepion Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Hepion Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Hepion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hepion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Hepion Pharmaceuticals stock market strength indicators, traders can identify Hepion Pharmaceuticals entry and exit signals to maximize returns.
Hepion Pharmaceuticals Risk Indicators
The analysis of Hepion Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Hepion Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hepion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.82 | |||
| Standard Deviation | 5.52 | |||
| Variance | 30.51 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:Check out Historical Fundamental Analysis of Hepion Pharmaceuticals to cross-verify your projections. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.40) | Return On Assets (0.93) | Return On Equity (1.90) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.